Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Infectious Diseases : Parainfluenza virus in immunocompromised patients
Currently there are no medications approved for the treatment of parainfluenza virus infection (PIV), including no effective treatment for PIV infection for the immunocompromised population (including persons undergoing autologous or allogeneic hematopoietic cell transplant, lung or heart-lung transplant, patients treated with chemotherapy for hematologic malignancies or solid organ malignancies) outside of supportive care (supplemental oxygen, corticosteroids, antibiotics). The purpose of this research study is to test the safety, effectiveness and tolerability of an investigational drug called DAS181 on study participants with a very weak immune system who are diagnosed with a PIV infection. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA). DAS181 will be given as a liquid aerosol spray using a nebulizer (a device used to turn liquids into mist for breathing treatments).
Because this is a research study, DAS181 will be given to you only during this study and not after the study is over.
Eligibility criteria, among others, include:
For the current eligibility status of this clinical study, referring physicians must contact St. Jude Children's Research Hospital at 1-866-2ST-JUDE (1-866-278-5833).
Ashok Srinivasan, MDSt. Jude Children’s Research Hospital
Referring or consulting physicians only: firstname.lastname@example.org
For all other inquiries about St. Jude Children's Research Hospital studies: email@example.com
The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.